{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:15:15Z","timestamp":1783487715151,"version":"3.55.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy of immunotherapy varies between MSI-H and MSS colorectal cancer(CRC) patients. Multiple studies have shown that gut microbiota is closely related to CRC, but the causality of them has yet to be fully established. This study aims to look for differential bacteria and related pathways by collecting feces from patients with different MS of CRC and healthy individuals, providing direction for immunotherapy of MSS CRC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>1. Explore the differences in gut microbiota between MSI-H and MSS CRC. 2.Provide new direction for the future clinical treatment of MSS CRC patients and improve their prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From October 2021 to December 2025, fecal samples and medical records were collected from healthy individuals and patients with different genotypes of MSS and MSI-H CRC admitted to Shandong Cancer Hospital and Institute. 28 fecal samples were collected from MSI-H, MSS CRC patients and healthy individuals respectively. Then 84 fecal samples were analyzed using 16S rDNA sequencing. Finally the differential microbial communities in the fecal samples of MSI-H and MSS CRC patients were analyzed based on the sequencing results, and healthy human fecal samples were used as controls to explore the role of differential microbial communities in CRC immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The collected 84 fecal samples were subjected to 16s rDNA sequencing analysis. Through Venn plot analysis, it was found that there are 1774 same bacterial species in MSS and MSI-H CRC patients, 3951 unique bacterial species in MSS CRC patients, and 2571 unique bacterial species in MSI-H CRC patients. The species richness of intestinal microbiota in MSS was higher than that in MSI-H CRC patients. Through species analysis, differential bacteria were identified among the samples submitted for testing, and further validation was obtained. Finally, based on the test results and comprehensive analysis of relevant literature, this study found that the bacteria with the most significant difference at phylum level between MSI-H and MSS CRC patients are Bacillota(p=0.024), Bacteroidota(p=0.024), Pseudomonadota(p=0.024), Actinomycetota(p=0.026), Verrucomicrobiota(p=0.037), and at genus level are Akkermansia(p=0.022), Alistipes(p=0.032), Anaerostipes(p=0.034), ASF356(p=0.016), Bacteroides(p=0.032), Bilophila(p=0.007), Coprococcus(p=0.037), Culicoidibacter(p=0.031), Enterocloster(p=0.049), Escherichia-Shigella(p=0.045), Faecalibacterium(0.042), Flavobacterium(p=0.037), Mediterraneibacter(p=0.037), Monoglobus(p=0.028), Oscillibacter(p=0.024), Parabacteroides(p=0.038), Ruthenibacterium(p=0.041), Streptococcus(p=0.015), Terrisporobacter(p=0.019), Tyzzerella(p=0.045), UCG-002(p=0.025), UCG-005(p=0.027), UCG-009(p=0.032), Veillonella(p=0.020). Among them, the relationship between Akkermansia, Faecalibactrium, Coprococcus and Bacteroides with immunotherapy is a hot research topic at home and abroad.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There are differences in the species composition of gut microbiota between MSI-H and MSS CRC patients, which may provide new directions for further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1729343","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:36:17Z","timestamp":1783485377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The characteristics of gut microbiota in colorectal cancer with different microsatellite states"],"prefix":"10.3389","volume":"16","author":[{"given":"Yao","family":"Yao","sequence":"first","affiliation":[{"name":"Department 2 of Colorectal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]},{"name":"Department of Bone and Soft Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Bingbing","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Junqi","sequence":"additional","affiliation":[{"name":"Department 2 of Colorectal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shandong Provincial Public Health Clinical Center","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xinyu","sequence":"additional","affiliation":[{"name":"Yongkang Orthopaedic Hospital, Yongkang Sixth People's Hospital","place":["Jinhua, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Yanlai","sequence":"additional","affiliation":[{"name":"Department 2 of Colorectal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2011.06.035","article-title":"Arsenic oxide targets stem cell marker CD133 \/prominin-1 in gallbladder carcinoma","volume":"310","author":"Ai","year":"2011","journal-title":"Cancer Lett."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215295","article-title":"The role of the gut microbiota in colorectal cancer causation","volume":"20","author":"Alhinai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B3","unstructured":"The Global Cancer Burden\n          \n          \n          \n          2024"},{"key":"B4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3164\/jcbn.15-152","article-title":"Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population","volume":"59","author":"Andoh","year":"2016","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.immuni.2025.10.004","article-title":"Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma","volume":"58","author":"Bachem","year":"2025","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-022-04985-7","article-title":"Akkermansia muciniphila phospholipid induces homeostatic immune responses","volume":"608","author":"Bae","year":"2022","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jor.24170","article-title":"Cellular biology of fracture healing","volume":"37","author":"Bahney","year":"2019","journal-title":"J. Orthop. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-micro-102215-095513","article-title":"Gut microbiota, inflammation, and colorectal cancer","volume":"70","author":"Brennan","year":"2016","journal-title":"Annu. Rev. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.chom.2025.05.007","article-title":"Bacteroides sphingolipids promote anti-inflammatory responses through the mevalonate pathway","volume":"33","author":"Brown","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: Paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-generation beneficial microbes: The case of Akkermansia muciniphila","volume":"8","author":"Cani","year":"2017","journal-title":"Front. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s12010-021-03498-9","article-title":"Exploring the role of gut microbiome in colon cancer","volume":"193","author":"Chattopadhyay","year":"2021","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.341.6149.954","article-title":"Medical research. The promise of poop","volume":"341","author":"De Vrieze","year":"2013","journal-title":"Sci. (New York NY)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101567","article-title":"Microsatellite instability: Diagnosis, heterogeneity, discordance, and clinical impact in colorectal cancer","volume":"11","author":"Evrard","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116416","article-title":"The role of Akkermansia muciniphila in colorectal cancer: A double-edged sword of treatment or disease progression","volume":"173","author":"Faghfuri","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13329","article-title":"Akkermansia muciniphila mediates negative effects of IFN\u03b3 on glucose metabolism","volume":"7","author":"Greer","year":"2016","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41467-019-08377-w","article-title":"Trait-based community assembly and succession of the infant gut microbiome","volume":"10","author":"Guittar","year":"2019","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7314\/apjcp.2014.15.6.2727","article-title":"Cancer incidence and mortality in China","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Center"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide","volume":"116","author":"Henke","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205090","article-title":"Unraveling resistance to immunotherapy in MSI-high colorectal cancer","volume":"15","author":"Heregger","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.993285","article-title":"Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0002_9440(10)63127_9","article-title":"Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences","volume":"145","author":"Kim","year":"1994","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-017-1027-1","article-title":"Association between body mass index and Firmicutes\/Bacteroidetes ratio in an adult Ukrainian population","volume":"17","author":"Koliada","year":"2017","journal-title":"BMC Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4020-8749-3_6","article-title":"Intestinal flora","volume":"639","author":"Kunz","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/jnci\/39.2.355","article-title":"Tumor induction in germfree rats with methylazoxymethanol (MAM) and synthetic MAM acetate","volume":"39","author":"Laqueur","year":"1967","journal-title":"J. Natl. Cancer Inst."},{"key":"B31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.csbj.2022.03.038","article-title":"Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives","volume":"20","author":"Li","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41586-025-09249-8","article-title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration","volume":"644","author":"Lin","year":"2025","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.634069","article-title":"Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer's disease","volume":"8","author":"Ling","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1171239","article-title":"The role of fecal Fusobacterium nucleatum and pks+ Escherichia coli as early diagnostic markers of colorectal cancer","volume":"2021","author":"Liu","year":"2021","journal-title":"Dis. Markers"},{"key":"B36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics","volume":"11","author":"Lopez-Siles","year":"2017","journal-title":"ISME J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/nejmra1600266","article-title":"Me human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","article-title":"Me gut microbiota and host health: A new clinical frontier","volume":"65","author":"Marchesi","year":"2016","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2022","journal-title":"Gut"},{"key":"B41","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/07420528.2022.2044349","article-title":"Changes in intestinal parameters and their association with dietary patterns in rotational shift workers","volume":"39","author":"Morta\u015f","year":"2022","journal-title":"Chronobiol. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"13455","DOI":"10.1038\/s41598-019-49878-4","article-title":"Tumor infiltrating lymphocytes and macrophages improve survival in microsatellite unstable colorectal cancer","volume":"9","author":"Narayanan","year":"2019","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41387-020-0115-8","article-title":"Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease","volume":"10","author":"Ou","year":"2020","journal-title":"Nutr. Diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","article-title":"Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease","volume":"143","author":"Qian","year":"2020","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B46","first-page":"287","article-title":"Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats","volume":"35","author":"Reddy","year":"1975","journal-title":"Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1016\/j.jalz.2017.07.172","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00978","article-title":"Targeting VEGF\/VEGFR to modulate antitumor immunity","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001966","article-title":"Progress in the investigation of the Firmicutes\/Bacteroidetes ratio as a potential pathogenic factor in ulcerative colitis","volume":"74","author":"Yin","year":"2025","journal-title":"J. Med. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","article-title":"Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1136\/gutjnl-2025-335306","article-title":"Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY+CD8+ T cells","volume":"74","author":"Zhang","year":"2025","journal-title":"Gut"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Sci. (New York NY)"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1729343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:36:27Z","timestamp":1783485387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1729343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":54,"alternative-id":["10.3389\/fcimb.2026.1729343"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1729343","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1729343"}}